Pharmacotherapy Agents in Lymphedema Treatment: A Systematic Review

It is estimated that one in every six patients undergoing solid cancer treatment will develop secondary lymphedema. We conducted a systematic review of publications assessing the potential use of pharmacotherapy agents in lymphedema treatment. The search was conducted on PubMed and eligibility crite...

Descripción completa

Detalles Bibliográficos
Autores principales: Forte, Antonio J, Boczar, Daniel, Huayllani, Maria T, Lu, Xiaona, McLaughlin, Sarah A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6897350/
https://www.ncbi.nlm.nih.gov/pubmed/31815082
http://dx.doi.org/10.7759/cureus.6300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6897350/
https://www.ncbi.nlm.nih.gov/pubmed/31815082
http://dx.doi.org/10.7759/cureus.6300

Ejemplares similares